Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease.

PubWeight™: 3.06‹?› | Rank: Top 1%

🔗 View Article (PMID 1729574)

Published in JAMA on February 10, 1992


R B Williams1, J C Barefoot, R M Califf, T L Haney, W B Saunders, D B Pryor, M A Hlatky, I C Siegler, D B Mark

Author Affiliations

1: Department of Psychiatry, Duke University Medical Center, Durham, NC 27710.

Articles citing this

Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01

Social support and health: a review of physiological processes potentially underlying links to disease outcomes. J Behav Med (2006) 5.85

Access to coronary catheterisation: fair shares for all? BMJ (1993) 3.45

A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28

The impact of socioeconomic status on health functioning as assessed by the SF-36 questionnaire: the Whitehall II Study. Am J Public Health (1997) 2.65

Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28

Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. CMAJ (2000) 2.12

Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction. CMAJ (2003) 1.76

Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status. CMAJ (2000) 1.74

All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997. Am J Public Health (2004) 1.70

Testing the performance of the ENRICHD Social Support Instrument in cardiac patients. Health Qual Life Outcomes (2004) 1.61

Impact of socioeconomic status on coronary mortality in people with symptoms, electrocardiographic abnormalities, both or neither: the original Whitehall study 25 year follow up. J Epidemiol Community Health (2000) 1.60

Marital status and ischemic heart disease incidence and mortality in women: a large prospective study. BMC Med (2014) 1.58

Principles help to analyse but often give no solution--secondary prevention after a cardiac event. Health Care Anal (2006) 1.44

Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med (2008) 1.43

Psychosocial stress and cardiovascular disease: pathophysiological links. Behav Med (2002) 1.26

Continued adverse trends in coronary heart disease mortality among blacks, 1980-91. Public Health Rep (1995) 1.23

A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc (2002) 1.21

Health status among 28,000 women veterans. The VA Women's Health Program Evaluation Project. J Gen Intern Med (2006) 1.11

Relation of low socioeconomic status to C-reactive protein in patients with coronary heart disease (from the heart and soul study). Am J Cardiol (2005) 1.11

Independent and mediated contributions of personality, coping, social support, and depressive symptoms to physical functioning outcome among patients in cardiac rehabilitation. J Behav Med (2004) 1.08

Feelings of parental caring predict health status in midlife: a 35-year follow-up of the Harvard Mastery of Stress Study. J Behav Med (1997) 1.07

The effect of social relationships on survival in elderly residents of a Southern European community: a cohort study. BMC Geriatr (2007) 1.06

Trust, health, and longevity. J Behav Med (1998) 1.04

Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association. Circulation (2013) 1.02

Longitudinal predictors of nonadherence to maintenance of mammography. Cancer Epidemiol Biomarkers Prev (2010) 1.01

Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin Neurosci (2007) 1.00

Are there gender differences in diabetes care among elderly Medicare enrolled veterans? J Gen Intern Med (2006) 0.99

Self-efficacy and health status in patients with coronary heart disease: findings from the heart and soul study. Psychosom Med (2007) 0.98

Are the economically active more deserving? Br Heart J (1995) 0.95

Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention. Behav Med (2002) 0.95

Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ (2004) 0.93

Psychological distress in primary care patients with heart failure: a longitudinal study. Br J Gen Pract (2007) 0.92

Psychosocial influences on mortality of patients with coronary heart disease. JAMA (1992) 0.90

Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS. J Am Heart Assoc (2014) 0.89

Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the Heart and Soul Study. Health Psychol (2009) 0.88

Social support, depression, and heart disease: a ten year literature review. Front Psychol (2013) 0.88

Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women. Fertil Steril (2008) 0.88

Sexual orientation and testing for prostate and colorectal cancers among men in California. Med Care (2008) 0.87

Are there socioeconomic differences in myocardial infarction event rates and fatality among patients with angina pectoris? J Epidemiol Community Health (2006) 0.86

Is hospital care involved in inequalities in coronary heart disease mortality? Results from the French WHO-MONICA Project in men aged 30-64. J Epidemiol Community Health (1998) 0.86

Heart and mind: (1) relationship between cardiovascular and psychiatric conditions. Postgrad Med J (2004) 0.84

Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med (2012) 0.83

Neighbourhood socioeconomics status predicts non-cardiovascular mortality in cardiac patients with access to universal health care. PLoS One (2009) 0.82

Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2008) 0.82

Changes in social support within the early recovery period and outcomes after acute myocardial infarction. J Psychosom Res (2012) 0.82

Perceived neighbourhood social cohesion and myocardial infarction. J Epidemiol Community Health (2014) 0.81

Health beliefs and desire to improve cholesterol levels among patients with hyperlipidemia. Patient Educ Couns (2015) 0.81

Adherence to risk factor management instructions after acute myocardial infarction: the role of emotional support and depressive symptoms. Ann Behav Med (2012) 0.81

Bridging research to action: a framework and decision-making process for cancer control. Advisory Committee on Cancer Control, National Cancer Institute of Canada. CMAJ (1994) 0.80

In Sickness and in Health: a Literature Review about Function of Social Support within Anxiety and Heart Disease Association. Clin Pract Epidemiol Ment Health (2013) 0.79

The role of stress and social support in predicting depression among a hypertensive African American sample. Heart Lung (2008) 0.79

Psychosocial factors are preventive against coronary events in Japanese men with coronary artery disease: The Eastern Collaborative Group Study 7.7-year follow-up experience. Biopsychosoc Med (2015) 0.78

Psychosocial Factors Associated with Subclinical Atherosclerosis in South Asians: The MASALA Study. J Immigr Minor Health (2016) 0.77

Standard and alternative adjunctive treatments in cardiac rehabilitation. Tex Heart Inst J (1993) 0.77

Myocardial infarction and risk of suicide: another reason to develop and test ways to reduce distress in postmyocardial-infarction patients? Circulation (2010) 0.77

Race differences in cardiac catheterization: the role of social contextual variables. J Gen Intern Med (2010) 0.77

The relationships among satisfaction with social support, quality of life, and survival 5 to 10 years after heart transplantation. J Cardiovasc Nurs (2013) 0.77

Effect of pranayama on rate pressure product in mild hypertensives. Int J Appl Basic Med Res (2014) 0.76

Predictors for waiting time for coronary angioplasty in a high risk population. Qual Health Care (1995) 0.75

The associations of coping mechanism with arterial stiffness in hwa-byung patients. Psychiatry Investig (2009) 0.75

Abstinence Reinforcement Therapy (ART) for rural veterans: Methodology for an mHealth smoking cessation intervention. Contemp Clin Trials (2016) 0.75

Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol (2015) 0.75

It's the amount of thought that counts: when ambivalence contributes to mammography screening delay. Womens Health Issues (2011) 0.75

Association of social support during emergency department evaluation for acute coronary syndrome with subsequent posttraumatic stress symptoms. J Behav Med (2016) 0.75

Personality and coping with a common stressor: cardiac catheterization. J Behav Med (2001) 0.75

Articles by these authors

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18

The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62

Evaluating the yield of medical tests. JAMA (1982) 14.05

Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med (2001) 11.56

Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med (1993) 8.75

Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62

Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09

Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78

Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med (1996) 6.68

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19

Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94

Social consequences of psychiatric disorders, I: Educational attainment. Am J Psychiatry (1995) 5.86

Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med (1997) 5.80

Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59

Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med (1996) 5.51

A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50

Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85

Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53

Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation (2000) 4.46

Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29

American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol (2001) 4.20

Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19

1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation (1999) 4.14

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69

Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol (2000) 3.54

Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39

The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med (1994) 3.39

Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. Psychosom Med (2001) 3.38

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38

Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med (1994) 3.32

Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22

ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol (1997) 3.14

Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11

The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation (2000) 3.02

A national estimate of the economic costs of asthma. Am J Respir Crit Care Med (1997) 2.97

Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (2000) 2.96

Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83

Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81

Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80

Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA (1997) 2.77

Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65

Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation (1999) 2.58

Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med (1996) 2.55

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53

Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52

Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med (1984) 2.49

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet (1994) 2.45

Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42

The role of coronary angiography and coronary revascularization before noncardiac vascular surgery. JAMA (1995) 2.38

The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA (1989) 2.33

The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly. J Am Coll Cardiol (1998) 2.30

Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30

Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA (2001) 2.29

ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27

Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. J Am Coll Cardiol (1999) 2.24

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23

Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Circulation (1997) 2.23

Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. J Am Coll Cardiol (1996) 2.23